Trifecta Signals

← Stocks · CLRB page

Cellectar Biosciences, Inc. (CLRB)

Price chart & company basics · Trifecta Signals

$1.15-$0.08 (-6.50%)Close · Thu, Nov 5, 2026

Price refreshes every trading day after the close.

In the scan since Jan 2022
CLRB closes
-65.6% 1Y · Range $1.12 – $4.04
$2$3$4 Nov ’25Jan ’26Mar ’26May ’26Jul ’26Sep ’26Nov ’26

Daily closes · through the most recent close

Price history from Jan 2018 · Signal tracking began Jan 2022

The Trifecta List

CLRB didn’t make the Trifecta List

Cellectar has never had a Trifecta signal in the record — not an Early signal, not a confirmed one — since the record began in January 2022. It is scanned after every trading day’s close along with the full US-listed universe; so far it has never met the conditions.

That’s the whole record for this stock: the chart and the basics above, and nothing to grade.

The list is the public track record: every stock that has signaled, logged, confirmed, and graded.

Cellectar Biosciences is a listed company whose shares trade under the CLRB ticker.

Over the past year the shares have traded between $1.12 and $4.04, and the latest close sits near the bottom of that range. From low to high, that range spans about 261%. Price history on this page reaches back to January 2018.

At the most recent close, Thursday, November 5, the shares finished at $1.15, down 6.5% on the day. Over the past week, the shares have traded in a range between about $1.15 and $1.31.

Download the CLRB report (PDF)Free edition — public summary · Data as of Nov 4, 2026